DEX-UP

This brand name is authorized in Nigeria.

Active ingredients

The drug DEX-UP contains one active pharmaceutical ingredient (API):

1	Dexamethasone UNII 7S5I7G3JQL - DEXAMETHASONE
	Dexamethasone is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. It has an approximately 7 times greater anti-inflammatory potency than prednisolone, another commonly prescribed corticosteroid. At high doses it reduces the immune response.
	Read more about Dexamethasone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-0206	Tablet	Dex-Up Tablets TAB 0.5 mg 1 x 1000's (in blister pack)	Uncoated Tablet 48 CMS-PP-341773 DEX-UP TABLETS DEXAMETHASONE 0.5MG EACH TABLET CONTAINS DEXAMETHASONE 0.5MG Excipients glycol (E1520), benzoic acid (E210), citric acid monohydrate (E330 B4-0206 Drugs Imported Products 1X1000 Prescription Only Medicine (POM) 7/11/2023 SUITELIFE PHARMACEUTICALS LTD, 4 ayo davis close off ekolonu street, surulere, lagos 8129419809 suitelifepharma@yahoo.com M/s JASH PHARMA PVT. LTD, NO. 143/144, SURAT SPECIAL ECONOMIC ZONE, NEAR SACHIN RAIL WAY STATION, SACHIN DIST-SURAT-394230 GUJARAT INDIA., India	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H02AB02	Dexamethasone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-0206